标题:Double-negative T Cells Inhibit Proliferation and Invasion of Human Pancreatic Cancer Cells in Co-culture
作者:Lu Y.; Hu P.; Zhou H.; Yang Z.; Sun Y.U.; Hoffman R.M.; Chen J.
作者机构:[Lu, Y] Department of General Surgery, Medical School of Shandong University, Jinan, China;[ Hu, P] Department of General Surgery, Anhui Provincial Ho 更多
来源:Anticancer research
出版年:2019
卷:39
期:11
页码:5911-5918
DOI:10.21873/anticanres.13795
关键词:cell proliferation invasion; Double-negative T cell; Nrf-2; pancreatic cancer
摘要:BACKGROUND/AIM: Double-negative T (DNT) cells are phenotypically CD3+CD4-CD8-T cells. This study aimed to investigate the anti-cancer activity of DNT cells against pancreatic cancer cells. MATERIALS AND METHODS: DNT cells were isolated from human peripheral blood. The effect of DNT cells on proliferation and invasion of the human pancreatic cell line Panc-1 was assessed. Expression of Nrf2 and Fas in Panc-1 cells co-cultured with DNT cells was analyzed with RT-PCR. The supernatants of Panc-1 and DNT co-cultures were analyzed with ELISA for IFN-r and FasL levels. RESULTS: The isolated DNT cell phenotype was CD4-CD8-CD56- CD3+TCR (T cell receptor) α/β+ T cells with more than 90% purity. Panc-1 cell proliferation was significantly inhibited by co-culture with DNT cells. Panc-1 cells co-cultured with DNT cells showed significantly reduced cell invasion. Panc-1 cells co-cultured with DNT cells showed increased Nrf2 and Fas mRNA expression. Increased INF-r and FasL levels were detected in the supernatants of co-cultures of DNT and pancreatic cells. CONCLUSION: DNT cells inhibited proliferation and invasion of human pancreatic cancer cells. The INF-r, Fas/FasL pathway and Nrf2 may be involved in the anti-cancer effect of DNT cells against human pancreatic cancer. Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
收录类别:SCOPUS
资源类型:期刊论文
原文链接:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074684944&doi=10.21873%2fanticanres.13795&partnerID=40&md5=82d496f068293e52edb53ad2880e1f2b
TOP